CAR-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer.
J Clin Endocrinol Metab
; 107(4): 1110-1126, 2022 03 24.
Article
in En
| MEDLINE
| ID: mdl-34751400
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Receptors, Chimeric Antigen
Limits:
Animals
/
Humans
Language:
En
Journal:
J Clin Endocrinol Metab
Year:
2022
Document type:
Article
Country of publication:
United States